The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 15, 2008

Filed:

Jan. 14, 2004
Applicants:

Bradley Paul Morgan, South San Francisco, CA (US);

Kathleen A. Elias, South San Francisco, CA (US);

Erica Anne Kraynack, South San Francisco, CA (US);

Pu-ping LU, South San Francisco, CA (US);

Fady Malik, South San Francisco, CA (US);

Alex Muci, South San Francisco, CA (US);

Xiangping Qian, South San Francisco, CA (US);

Whitney Walter Smith, South San Francisco, CA (US);

Todd Tochimoto, South San Francisco, CA (US);

Adam Lewis Tomasi, South San Francisco, CA (US);

David J. Morgans, Jr., South San Francisco, CA (US);

Inventors:

Bradley Paul Morgan, South San Francisco, CA (US);

Kathleen A. Elias, South San Francisco, CA (US);

Erica Anne Kraynack, South San Francisco, CA (US);

Pu-Ping Lu, South San Francisco, CA (US);

Fady Malik, South San Francisco, CA (US);

Alex Muci, South San Francisco, CA (US);

Xiangping Qian, South San Francisco, CA (US);

Whitney Walter Smith, South San Francisco, CA (US);

Todd Tochimoto, South San Francisco, CA (US);

Adam Lewis Tomasi, South San Francisco, CA (US);

David J. Morgans, Jr., South San Francisco, CA (US);

Assignee:

Cytokinetics, Inc., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 211/68 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, are useful in the treatment of systolic heart failure including congestive heart failure.


Find Patent Forward Citations

Loading…